Calcium channel blockers comprising two benzhydril moieties

Details Calcium channel blockers comprising two benzhydril moieties Calcium channel blockers comprising two benzhydril moieties

2005-09-27

2005-09-27

Henley, III, Raymond J. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S254110, C514S255010

Reexamination Certificate

active

06949554

ABSTRACT:
Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.

REFERENCES:
patent: 3288795 (1966-11-01), Irikura et al.
patent: 4188485 (1980-02-01), Kukla
patent: 4918073 (1990-04-01), Ruger et al.
patent: 5386025 (1995-01-01), Jay et al.
patent: 5428038 (1995-06-01), Chatterjee et al.
patent: 5623051 (1997-04-01), Catterall et al.
patent: 5646149 (1997-07-01), Hellberg et al.
patent: 5703071 (1997-12-01), Itoh et al.
patent: 5866574 (1999-02-01), Okamura et al.
patent: 6011035 (2000-01-01), Snutch et al.
patent: 6294533 (2001-09-01), Snutch et al.
patent: 6310059 (2001-10-01), Snutch
patent: 6387897 (2002-05-01), Snutch
patent: 6458781 (2002-10-01), Connor et al.
patent: 6492375 (2002-12-01), Snutch
patent: 2001/0029258 (2001-10-01), Snutch
patent: 2004/0034035 (2004-02-01), Snutch et al.
patent: 2335461 (1999-06-01), None
patent: 2394327 (2001-06-01), None
patent: 0 187 524 (1986-07-01), None
patent: 0 213 006 (1987-03-01), None
patent: 0 458 387 (1991-11-01), None
patent: 0 496 691 (1992-07-01), None
patent: 504 202 (1983-01-01), None
patent: 514 167 (1983-04-01), None
patent: 8 304 135 (1983-05-01), None
patent: 8 305 343 (1983-07-01), None
patent: 920 416 (1963-03-01), None
patent: 1 513 883 (1978-06-01), None
patent: WO 94/14786 (1994-07-01), None
patent: WO 99/15129 (1999-04-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 00/01375 (2000-01-01), None
patent: WO 00/18402 (2000-04-01), None
patent: WO 00/37059 (2000-06-01), None
patent: WO 01/45709 (2001-06-01), None
patent: WO-01/49670 (2001-07-01), None
patent: WO-03/068759 (2003-08-01), None
Boger et al., Helvetica Chimica Acta (2000) 83(8):1825-1845.
International Search Report for PCT/CA2004/000539, mailed on Dec. 22, 2004, 9 pages.
International Search Report for PCT/CA2004/001629, mailed on Jan. 21, 2005, 6 pages.
Jamieson et al., Synlett (2000) 11:1603-1607.
Toldy et al., Acta Chimica Academiae Scientiarum Hungarica (1965) 44:301-325.
Webster et al., Journal of the Chemical Society (2001 14:1673-1695.
International Search Report for PCT/CA2004/000535, mailed on Jul. 1, 2004, 5 pages.
Invitation to Pay Additional Fees for PCT/CA2004/000539, mailed on Sep. 2, 2004, 6 pages.
Bourinet et al. (1999).Nature Neuro2:407-415.
Chiarini, A. et al. (1996).Bioorg&Med Chem4(10):1629-1635.
Cohan, S. et al. (1991).Anns NY Acad Sci635:397-399.
Cribbs et al. (1998).Circ Res83:103-109.
Database WPI Week 9711 Derwent Publications Ltd., London, GB; Abstract JP 09 003067, XP002133055 (Hisamitsu Pharm Co Ltd.) Jan. 7, 1997.
De Waard et al. (1997).Ion ChannelsNarahashi, T. ed. Plenum Press, NY 4:41-87.
Dhainaut et al. (1992).J Med Chem35:2481-2496.
Dooley (1999).Current Op CPNS Investig Drugs1(1):116-125.
Dunlap et al. (1995).Trends Neurosci18:89-98.
Estep, K. et al. (1995).J Med Chem38(14):2582-2595.
Galizzi et al. (1986).PNAS USA83: 7513-7517.
Glamkowski, E. et al. (1977).J Med Chem20(11):1485-1489.
Gould et al. (1983).PNAS USA80:5122-5125.
Grantham et al. (1994).Brit J Pharmacol111:438-488.
Ito et al. (1994).Eur J Pharmacol257:203-210.
King et al. (1989).J Biol Chem264:5633-5641.
Lee et al. (1999).J Neurosci19:1912-1921.
Lehmann et al. (1988).Archiv der Pharmazie321(11):807-812.
McCleskey et al. (1991).Curr Topics Membr39:295-326.
Miyano, S. et al. (1990).Chem Pharm Bull38(6):1570-1574.
Ohtaka, H. et al. (1987).Chem Pharm Bull35(8):3270-3275.
Ohtaka, H. et al. (1987).Chem Pharm Bull35(10):4117-4123.
Perez-Reyes et al. (1998).Nature391:896-900.
Prasad, R. et al. (1968).J Med Chem11(6):1144-1150.
Sather et al. (1993).Neuron11:291-303.
Stea et al. (1994).PNAS USA91:10576-10580.
Stea et al.Handbook of Receptors and Channels(North, R.A. ed. CRC Press 1995) 113-151.
Tytgat, J. et al. (1991).Brain Res549(1):112-117.
Uneyama, H. et al. (1998).Calcium Ion Modulators, Sel Pap Satell Symp 13-23.
Vadodaria, D. et al. (1969).J Med Chem12:860-865.
Zikolova, S. et al. (1972).Tr. Nauchnoizsled Khim-Farm Inst8:59-67.
Zikolova, S. et al. (1984).Tr. Nauchnoizsled Khim-Farm Inst14:23-28.

Affiliated with

Also associated with

Rating

Calcium channel blockers comprising two benzhydril moieties does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Calcium channel blockers comprising two benzhydril moieties, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium channel blockers comprising two benzhydril moieties will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3422903